
How are melanocytic lesions assessed?
Your healthcare provider conducts a head-to-toe examination of your skin to identify any suspicious moles or growths. If there is concern, the mole will be removed (a skin biopsy) and sent to a dermatopathologist.
Dermatopathologists are highly trained physicians who specialize in the diagnosis of skin disorders using microscopes and laboratory tests. The dermatopathologist interprets the biopsy findings and reports them to your healthcare provider.
How does our test help guide your care?
Most moles are easily diagnosed as benign or malignant, however, even the most experienced dermatopathologists occasionally cannot be entirely certain of the diagnosis using the microscope alone.
The MyPath Melanoma test may be ordered by the dermatopathologist or dermatologist to gather additional information.
This testing analyzes the biopsy specimen at the molecular level to help determine its diagnosis. These results, along with information obtained by examining the mole under the microscope, are analyzed by healthcare providers to arrive at a more accurate diagnosis. A more accurate diagnosis will guide your healthcare provider in developing the most appropriate treatment path for you going forward.

More clarity, less ambiguity for patient management
The test results are split into three categories: suggestive of benign, intermediate (cannot rule out malignancy), or suggestive of malignant. This information along with all other clinical and pathological findings will assist your pathologist when rendering a diagnosis and guide your healthcare provider in developing the most appropriate treatment plan.
Suggestive of benign
Low risk of your mole being cancerous
Intermediate
Intermediate results cannot be classified as suggestive of benign or suggestive of malignant.
Suggestive of malignant
High risk of your mole being cancerous